Global Nuclear Receptor ROR-Gamma Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Nuclear Receptor ROR-Gamma Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Product
  • 1.4.2 VPR-66
  • 1.4.3 INV-17
  • 1.4.4 GSK-2981278
  • 1.4.5 BBI-6000
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Nuclear Receptor ROR-Gamma Market Size
  • 2.1.1 Global Nuclear Receptor ROR-Gamma Revenue 2014-2025
  • 2.1.2 Global Nuclear Receptor ROR-Gamma Sales 2014-2025
• 2.2 Nuclear Receptor ROR-Gamma Growth Rate by Regions
  • 2.2.1 Global Nuclear Receptor ROR-Gamma Sales by Regions
  • 2.2.2 Global Nuclear Receptor ROR-Gamma Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Nuclear Receptor ROR-Gamma Sales by Manufacturers
  • 3.1.1 Nuclear Receptor ROR-Gamma Sales by Manufacturers
  • 3.1.2 Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturers
  • 3.1.3 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI)
• 3.2 Nuclear Receptor ROR-Gamma Revenue by Manufacturers
  • 3.2.1 Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2014-2019)
  • 3.2.2 Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2014-2019)
• 3.3 Nuclear Receptor ROR-Gamma Price by Manufacturers
• 3.4 Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Product Types
  • 3.4.1 Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Nuclear Receptor ROR-Gamma Product Type
  • 3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Nuclear Receptor ROR-Gamma Sales by Product
• 4.2 Global Nuclear Receptor ROR-Gamma Revenue by Product
• 4.3 Nuclear Receptor ROR-Gamma Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Nuclear Receptor ROR-Gamma Breakdown Data by End User

6 North America

• 6.1 North America Nuclear Receptor ROR-Gamma by Countries
  • 6.1.1 North America Nuclear Receptor ROR-Gamma Sales by Countries
  • 6.1.2 North America Nuclear Receptor ROR-Gamma Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Nuclear Receptor ROR-Gamma by Product
• 6.3 North America Nuclear Receptor ROR-Gamma by End User

7 Europe

• 7.1 Europe Nuclear Receptor ROR-Gamma by Countries
  • 7.1.1 Europe Nuclear Receptor ROR-Gamma Sales by Countries
  • 7.1.2 Europe Nuclear Receptor ROR-Gamma Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Nuclear Receptor ROR-Gamma by Product
• 7.3 Europe Nuclear Receptor ROR-Gamma by End User

8 Asia Pacific

• 8.1 Asia Pacific Nuclear Receptor ROR-Gamma by Countries
  • 8.1.1 Asia Pacific Nuclear Receptor ROR-Gamma Sales by Countries
  • 8.1.2 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Nuclear Receptor ROR-Gamma by Product
• 8.3 Asia Pacific Nuclear Receptor ROR-Gamma by End User

9 Central & South America

• 9.1 Central & South America Nuclear Receptor ROR-Gamma by Countries
  • 9.1.1 Central & South America Nuclear Receptor ROR-Gamma Sales by Countries
  • 9.1.2 Central & South America Nuclear Receptor ROR-Gamma Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Nuclear Receptor ROR-Gamma by Product
• 9.3 Central & South America Nuclear Receptor ROR-Gamma by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Nuclear Receptor ROR-Gamma by Countries
  • 10.1.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Countries
  • 10.1.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Nuclear Receptor ROR-Gamma by Product
• 10.3 Middle East and Africa Nuclear Receptor ROR-Gamma by End User

11 Company Profiles

• 11.1 4SC AG
  • 11.1.1 4SC AG Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 4SC AG Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered
  • 11.1.5 4SC AG Recent Development
• 11.2 Advinus Therapeutics Ltd.
  • 11.2.1 Advinus Therapeutics Ltd. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Products Offered
  • 11.2.5 Advinus Therapeutics Ltd. Recent Development
• 11.3 Arrien Pharmaceuticals, LLC
  • 11.3.1 Arrien Pharmaceuticals, LLC Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Products Offered
  • 11.3.5 Arrien Pharmaceuticals, LLC Recent Development
• 11.4 Aurigene Discovery Technologies Limited
  • 11.4.1 Aurigene Discovery Technologies Limited Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Products Offered
  • 11.4.5 Aurigene Discovery Technologies Limited Recent Development
• 11.5 Biogen, Inc.
  • 11.5.1 Biogen, Inc. Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Products Offered
  • 11.5.5 Biogen, Inc. Recent Development
• 11.6 Brickell Biotech, Inc.
  • 11.6.1 Brickell Biotech, Inc. Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Products Offered
  • 11.6.5 Brickell Biotech, Inc. Recent Development
• 11.7 Bristol-Myers Squibb Company
  • 11.7.1 Bristol-Myers Squibb Company Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Products Offered
  • 11.7.5 Bristol-Myers Squibb Company Recent Development
• 11.8 Celgene Corporation
  • 11.8.1 Celgene Corporation Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Products Offered
  • 11.8.5 Celgene Corporation Recent Development
• 11.9 Genentech, Inc.
  • 11.9.1 Genentech, Inc. Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Products Offered
  • 11.9.5 Genentech, Inc. Recent Development
• 11.10 Genfit SA
  • 11.10.1 Genfit SA Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Genfit SA Nuclear Receptor ROR-Gamma Products Offered
  • 11.10.5 Genfit SA Recent Development
• 11.11 GlaxoSmithKline Plc
• 11.12 Hanmi Pharmaceuticals, Co. Ltd.
• 11.13 Karo Bio AB
• 11.14 Lead Pharma Holding B.V.
• 11.15 Nuevolution AB
• 11.16 Phenex Pharmaceuticals AG
• 11.17 Reata Pharmaceuticals, Inc.
• 11.18 Teijin Pharma Limited
• 11.19 Visionary Pharmaceuticals, Inc.
• 11.20 Vitae Pharmaceuticals, Inc.

12 Future Forecast

• 12.1 Nuclear Receptor ROR-Gamma Market Forecast by Regions
  • 12.1.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Regions 2019-2025
• 12.2 Nuclear Receptor ROR-Gamma Market Forecast by Product
  • 12.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Product 2019-2025
  • 12.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Product 2019-2025
• 12.3 Nuclear Receptor ROR-Gamma Market Forecast by End User
• 12.4 North America Nuclear Receptor ROR-Gamma Forecast
• 12.5 Europe Nuclear Receptor ROR-Gamma Forecast
• 12.6 Asia Pacific Nuclear Receptor ROR-Gamma Forecast
• 12.7 Central & South America Nuclear Receptor ROR-Gamma Forecast
• 12.8 Middle East and Africa Nuclear Receptor ROR-Gamma Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Nuclear Receptor ROR-Gamma Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details